Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer.AuthorsPienta, Kenneth; Machiels, Jean-Pascal; Schrijvers, Dirk; Alekseev, Boris; Shkolnik, Mikhail; Crabb, Simon; Li, Susan; Seetharam, Shobha; Puchalski, Thomas; Takimoto, Chris; Elsayed, Yusri; Dawkins, Fitzroy; Bono, JohannPublicationInvestigational New Drugs, 2013, Vol 31, Issue 3, p760ISSN0167-6997Publication typeArticleDOI10.1007/s10637-012-9869-8